Document is current
Any future updates will be listed below
-
Authors
Heyman, Ylva https://orcid.org/0000-0003-1301-9360
Röjlar, Hanna
Hawranek, Carolina https://orcid.org/0000-0003-2218-6881
Numan Hellquist, Barbro https://orcid.org/0000-0002-2618-7358
Rosén, Anna https://orcid.org/0000-0003-2441-2395
-
Funding
Funding for this research was provided by:
Umea University
- License Information
-
More Information
Article History
Received: 1 December 2025
Accepted: 26 January 2026
First Online: 12 February 2026
Declarations
:
: Y.H. has received honoraria for lectures from AstraZeneca. H.R., C.H., B.N.H., and A.R. declare no conflicts of interest.
: Written informed consent was obtained from all individual participants included in the study.
: This manuscript does not contain any individual person’s data in any form.
: The study was approved by the Swedish Ethical Review Authority (Dnr 2019–02647, June 19, 2019), with subsequent amendments approved under Dnr 2020–01176 (May 18, 2020), Dnr 2021–00718 (March 11, 2021), and Dnr 2021–05890 (December 15, 2021). Data were de-identified prior to analysis, and the study was conducted in accordance with the principles of the Declaration of Helsinki.
